Expression and characterization of a recombinant soluble form of bovine tumor necrosis factor receptor type I

被引:5
|
作者
Mwangi, SM
Stabel, J [1 ]
Lee, EK
Kehrli, ME
Taylor, MJ
机构
[1] ARS, Natl Anim Dis Ctr, USDA, Ames, IA 50010 USA
[2] Iowa State Univ, Coll Vet Med, Dept Biomed Sci, Ames, IA 50010 USA
关键词
tumor necrosis factor alpha; receptor; expression; Pichia; bovine;
D O I
10.1016/S0165-2427(00)00244-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A recombinant soluble bovine tumor necrosis factor receptor type I (sboTNF-RI) was expressed in the methylotrophic yeast Pichia pastoris and evaluated for its ability to inhibit bovine tumor necrosis factor alpha (TNF-alpha) cytotoxicity. A cDNA encoding the extracellular domain of bovine TNF-RI was placed under the control of the powerful and tightly regulated alcohol oxidase1 (AOX1) gene promoter of the pPICZa A vector and the resulting construct integrated into the 5' region of the alcohol oxidase genes of GS 115 and KM71 strains of Pichia. Soluble bovine TNF-RI was secreted into the medium following induction of the AOX1 gene promoter with methanol, and purified to greater than 95% purity by ion-exchange chromatography. In in vitro assays, the purified recombinant sboTNF-RI will block the cytolytic activity of bovine TNF-alpha on WEHI 161 cells clone 13 by 50% when used at a concentration of 170 mug/ml, and by nearly 90% when used at a concentration of 310 mug/ml. Results of this study suggest that recombinant sboTNF-RI may have therapeutic value as a TNF inhibitor in cattle with coliform mastitis. Published by Elsevier Science B.V.
引用
收藏
页码:233 / 241
页数:9
相关论文
共 50 条
  • [41] Soluble tumor necrosis factor receptor I (sTNFRI) as a prognostic factor in melanoma patients in Slovene population
    Vesna Galvani
    Katrina Pretnar Hartman
    Ruth R. Rupreht
    Srdjan Novaković
    Borut Štabuc
    Janja Ocvirk
    Viktor Menart
    Vladimira Gaberc Porekar
    Anton Štalc
    Primož Rožman
    Vladka Čurin Šerbec
    Pflügers Archiv - European Journal of Physiology, 2000, 440 : R061 - R063
  • [42] Clinical pharmacokinetics of etanercept: A fully humanized soluble recombinant tumor necrosis factor receptor fusion protein
    Zhou, HH
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (05): : 490 - 497
  • [43] Induction of tumor necrosis factor receptor type 2 gene expression by tumor necrosis factor-α in rat primary astrocytes
    Lung, HL
    Leung, KN
    Stadlin, A
    Ma, CM
    Tsang, D
    LIFE SCIENCES, 2001, 68 (18) : 2081 - 2091
  • [44] Balancing Tumor Necrosis Factor Receptor I and Tumor Necrosis Factor Receptor II Jointly for Joint Inflammation
    Aggarwal, Bharat B.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 (10) : 2657 - 2660
  • [45] EFFECT OF CHRONIC ADMINISTRATION OF RECOMBINANT BOVINE TUMOR NECROSIS FACTOR TO CATTLE
    OHMANN, HB
    CAMPOS, M
    SNIDER, M
    RAPIN, N
    BESKORWAYNE, T
    POPOWYCH, Y
    LAWMAN, MJP
    ROSSI, A
    BABIUK, LA
    VETERINARY PATHOLOGY, 1989, 26 (06) : 462 - 472
  • [46] Generation of truncated recombinant form of tumor necrosis factor receptor-1 to produce cancer vaccine
    Hatamihanza, Hamide
    Hashemi, Mehrdad
    Akbarzadeh, Azim
    Fotouhi, Fatemeh
    Farahmand, Behrokh
    Shahmabadi, Hasan Ebrahimi
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2016, 15 (11) : 2345 - 2350
  • [47] Soluble tumor necrosis factor receptor in serum of patients with arthritis
    Lee, CS
    Chen, KH
    Wang, PC
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 1997, 96 (08) : 573 - 578
  • [48] Initiation of liver growth by tumor necrosis factor: Deficient liver regeneration in mice lacking type I tumor necrosis factor receptor
    Yamada, Y
    Kirillova, I
    Peschon, JJ
    Fausto, N
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (04) : 1441 - 1446
  • [49] INTERLEUKIN-1 CONTRIBUTES TO INCREASED CONCENTRATIONS OF SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR-TYPE-I IN SEPSIS
    VANDERPOLL, T
    FISCHER, E
    COYLE, SM
    VANZEE, KJ
    PRIBBLE, JP
    STILES, DM
    BARIE, PS
    BUURMAN, WA
    MOLDAWER, LL
    LOWRY, SF
    JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (02): : 577 - 580
  • [50] Photostability of soluble tumor necrosis factor receptor type-I: Effects of wavelength protein concentration, pH and dioxygen.
    Roy, S
    Mason, BD
    Hoonsiri, V
    Le, J
    Kerwin, BA
    Boone, TC
    Sitney, K
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U199 - U199